Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

6
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
6
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

23
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
23
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

7
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
7
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

18
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
18
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

150
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
150

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital Twin Applications in Diabetes Management: Scoping Review.

JMIR diabetes·2026
Same author

Peer Support in Online Women's Health Communities: Mixed Methods Formative Analysis of Reddit Discourse.

JMIR formative research·2026
Same author

Privacy-Preserving Collaborative Diabetes Prediction in Heterogeneous Health Care Systems: Algorithm Development and Validation of a Secure Federated Ensemble Framework.

JMIR diabetes·2026
Same author

Technologies, Clinical Applications, and Implementation Barriers of Digital Twins in Precision Cardiology: Systematic Review.

JMIR cardio·2026
Same author

Privacy-Preserving Glycemic Management in Type 1 Diabetes: Development and Validation of a Multiobjective Federated Reinforcement Learning Framework.

JMIR diabetes·2025
Same author

Optimizing Nutritional Decisions: A Particle Swarm Optimization-Simulated Annealing-Enhanced Analytic Hierarchy Process Approach for Personalized Meal Planning.

Nutrients·2024
Same journal

Multimodule Human-Artificial Intelligence Collaboration Pipeline for Large Language Model-Assisted Thematic Analysis Across Digital Health Interview Studies: Comparative Evaluation Study.

JMIR medical informatics·2026
Same journal

Graph Network Feature Space Fusion for Predicting Irregularly Sampled Medical Time-Series Data: Deep Learning Model Development and Validation Study.

JMIR medical informatics·2026
Same journal

Intrasystem Repeatability of S-Detect for Breast Ultrasound Classification With Identical Static Images: Single-Center Retrospective Repeatability Study.

JMIR medical informatics·2026
Same journal

Clinician Perspectives on Ambient AI Scribes in the Intensive Care Unit: Qualitative Interview Study.

JMIR medical informatics·2026
Same journal

IdeaDistiller-AI Support for Idea Synthesis in Concept Mapping: Algorithm Development and Validation Study.

JMIR medical informatics·2026
Same journal

Pregnancy-Related Clinical Codes in Unlikely Populations in Primary Care.

JMIR medical informatics·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K

Modeling Diabetes Risk and Progression With Public Health Data: Ontology-Guided, Simulation-Capable Digital Twin

Qingrui Li1, Kapileshwor Ray Amat1, Eric L Johnson2

  • 1Department of Computer Science, North Dakota State University, PO Box 6050, NDSU Dept #2455, Fargo, ND, 58108, United States, 1 7012319662.

JMIR Medical Informatics
|April 21, 2026
PubMed
Summary
This summary is machine-generated.

This study developed a framework for creating digital twins (DTs) from public health data to predict disease progression. The approach uses ontologies and LLMs to build simulation-capable DTs, enabling "what-if" analyses for health insights.

Keywords:
digital twinMIDUSMidlife in the United Stateschronic diseasediabeteslarge language modelsmultiagent AIontologiespublic health datasetsrisk predictionsimulation

More Related Videos

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

11.5K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K

Related Experiment Videos

Last Updated: Apr 23, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K
An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

11.5K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.1K

Area of Science:

  • Digital Health
  • Computational Biology
  • Health Informatics

Background:

  • Digital twins (DTs) offer potential for personalized healthcare but are limited by data scarcity and lack of standardization.
  • Existing DT studies often use narrow or proprietary datasets, hindering generalizability.
  • Public health datasets are rich but underutilized due to complexity and lack of semantic integration.

Purpose of the Study:

  • Develop and evaluate an ontology-guided, agent-orchestrated framework for building simulation-capable DTs from public health data.
  • Utilize large language models (LLMs) for semantic reasoning to support explainable feature structuring and risk prediction.
  • Enable predictive "what-if" progression analysis for chronic diseases like diabetes.

Main Methods:

  • Applied a 6-stage DT framework to the Midlife in the United States study data (waves 2 and 3).
  • Used ontology- and LLM-assisted selection to identify 200 key predictors across biological, behavioral, psychosocial, and socioeconomic domains.
  • Trained predictive models (random forest, XGBoost, logistic regression) and implemented a state-transition simulator for progression modeling and scenario analysis.

Main Results:

  • Selected 200 relevant predictors from 9976 variables using ontology and LLM guidance.
  • Achieved strong predictive performance for diabetes onset (e.g., Random Forest AUC=0.82).
  • Simulator showed realistic risk state transitions (92.5% next-state prediction accuracy) and demonstrated potential impact of interventions like weight reduction.

Conclusions:

  • Presents a foundational framework for creating progression-aware DTs from public datasets.
  • Transforms static population data into interpretable, longitudinal health trajectory representations.
  • Demonstrates the utility of public health data for robust, explainable DT models for risk analysis and hypothesis generation.